million 4.10 2. The operation results (from the consolidated finance statements) Item Second quarter of 2019 Second quarter of 2018 Profit (Loss) for three months attributable to equity holders of the

the details, terms and conditions and other procedures for the benefits of the disposal of shares and the entry into shares purchase agreement and any other documents related thereto and the power to

finance statements) Item 2019 2018 Profit (Loss) for the year attributable to equity holders of the Company (from the consolidated financial statements) Baht (515.22) million Baht 418.04 million Profit

Baht 5.79 million 11.25 2. The operation results (from the consolidated finance statements) Item Third quarter of 2019 Third quarter of 2018 Profit (Loss) for three months attributable to equity holders

Company Limited would like to inform on company meeting agreement held on 13 November 2017 as follows; 1. The approval on Vanachai Energy Industries Company Limited (subsidiary company) to increase the

Group Public Company Limited would like to inform on company meeting agreement held on 13 November 2017 as follows; 1. The approval on Vanachai Energy Industries Company Limited (subsidiary company) to

purchase and sale agreement 312.0 4.7 - - (312.0) (100.0) Gain on disposals of investments in subsidiaries - - 272.1 4.0 272.1 100.0 Other income 129.0 1.9 268.6 4.0 139.5 108.1 Total Revenues 6,657.3 100.0

%) Administrative expenses (94.34 ) (95.86 ) (1.52 ) 1.59% (53.71%) (32.40%) Other Expenses Loss on cancel of joint venture agreement - (25.50 ) 25.50 (100.00%) 0.00% (8.62%) Impairment loss of land held for

debt to equity ratio 0.35 times, shown that its sufficient liquidity and strong financial position. Please be informed accordingly, Yours Sincerely, DOD Biotech Public Company Limited (Miss Suwarin

Company still had current ratio 1.34 times and debt to equity ratio 0.38 times, shown that its sufficient liquidity and strong financial position. Please be informed accordingly, Yours Sincerely, DOD